Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine/Dexmedetomidine vs Nalbuphine/Propofol for Cataract Sedation
NCT03933280Phase 2Completed
- Sponsor
- Menoufia University
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in cataract, sponsored by Menoufia University. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03933280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03933280.